AAAAAA

   
Results: 1-9 |
Results: 9
Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196
Authors: Sparano, JA O'Neill, A Schaefer, PL Falkson, CI Wood, WC
Citation: Ja. Sparano et al., Phase II trial of doxorubicin and docetaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: Eastern Cooperative Oncology Group Study E1196, J CL ONCOL, 18(12), 2000, pp. 2369-2377
Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: Results from the Eastern Cooperative Oncology Group companion study, EST 4189
Authors: Simpson, JF Gray, R Dressler, LG Cobau, CD Falkson, CI Gilchrist, KW Pandya, KJ Page, DL Robert, NJ
Citation: Jf. Simpson et al., Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: Results from the Eastern Cooperative Oncology Group companion study, EST 4189, J CL ONCOL, 18(10), 2000, pp. 2059-2069
21-day oral etoposide for metastatic breast cancer - A phase II study and review of the literature
Authors: Saphner, T Weller, EA Tormey, DC Pandya, KJ Falkson, CI Stewart, J Robert, NJ
Citation: T. Saphner et al., 21-day oral etoposide for metastatic breast cancer - A phase II study and review of the literature, AM J CL ONC, 23(3), 2000, pp. 258-262
Treatment of squamous cell esophageal cancer with topotecan - An Eastern Cooperative Oncology Group study (E2293)
Authors: Asbury, RF Lipsitz, S Graham, D Falkson, CI Baez, L Benson, AB
Citation: Rf. Asbury et al., Treatment of squamous cell esophageal cancer with topotecan - An Eastern Cooperative Oncology Group study (E2293), AM J CL ONC, 23(1), 2000, pp. 45-46
Absence of commonly recurring BRCA1 mutations in black South African womenwith breast cancer
Authors: Yawitch, TM van Rensburg, EJ Mertz, M Falkson, CI
Citation: Tm. Yawitch et al., Absence of commonly recurring BRCA1 mutations in black South African womenwith breast cancer, S AFR MED J, 90(8), 2000, pp. 788-788
Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: An eastern cooperative oncology group study
Authors: Sparano, JA Hu, P Rao, RM Falkson, CI Wolff, AC Wood, WC
Citation: Ja. Sparano et al., Phase II trial of doxorubicin and paclitaxel plus granulocyte colony-stimulating factor in metastatic breast cancer: An eastern cooperative oncology group study, J CL ONCOL, 17(12), 1999, pp. 3828-3834
Carcinoma of unknown primary site - Leave it unknown
Authors: McMichael, GB Falkson, CI
Citation: Gb. Mcmichael et Ci. Falkson, Carcinoma of unknown primary site - Leave it unknown, S AFR MED J, 89(8), 1999, pp. 844-845
A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma
Authors: Falkson, CI Falkson, G
Citation: Ci. Falkson et G. Falkson, A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma, ONCOL-BASEL, 57(3), 1999, pp. 232-235
Hepatocellular carcinoma
Authors: Falkson, G Falkson, CI Garbers, LM
Citation: G. Falkson et al., Hepatocellular carcinoma, CANC TREAT, 98, 1998, pp. 83-109
Risultati: 1-9 |